DanCann Pharma A/S: The Board of Directors has resolved on a partially (48.88 percent) secured Rights Issue of approximately DKK 18.33 million and publishes memorandum
COPENHAGEN, Denmark, 24 May 2024 – DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announces that the Board of Directors of DanCann Pharma today has formally resolved on the previously announced partially (48.88 percent) guaranteed rights issue of shares with a total offer volume of approx. DKK 18.33 million (the “Rights Issue”). The resolution was adopted based on the authorisation from the extraordinary general meeting of the Company held on the 17 April 2024.The Rights Issue in short: · The Offer is comprised by a